Thiadiazine thione derivatives as anti-leishmanial agents: synthesis, biological evaluation, structure activity relationship, ADMET, molecular docking and molecular dyanamics simulation studies.
暂无分享,去创建一个
S. Khan | T. Htar | M. Lodhi | M. Naeem | M. Ibrahim | M. Ateeq | A. Zada | Amneh Shtaiwi | Muhammad Ishaq Ali Shah | Tamanna | Sher Wali Khan | Rasool Khan | Chaoping Fu | Arif Ali | Meshil Qadir | Tamanna
[1] J. Igoli,et al. Screening of traditional medicinal plant extracts and compounds identifies a potent anti-leishmanial diarylheptanoid from Siphonochilus aethiopicus , 2023, Journal of biomolecular structure & dynamics.
[2] A. Cao,et al. The Appropriate Particle Size of Dazomet Can Ensure the Soil Fumigation Effect from the Source , 2022, Agriculture.
[3] Nevin Süleymanoğlu,et al. Bis-1,2,4-triazol derivatives: Synthesis, characterization, DFT, antileishmanial activity and molecular docking study , 2022, Journal of biomolecular structure & dynamics.
[4] Arabinda Ghosh,et al. Leishmanicidal and cytotoxic activity of essential oil from the fruit peel of Myrciaria floribunda (H. West ex Willd.) O. Berg: Molecular docking and molecular dynamics simulations of its major constituent onto Leishmania enzyme targets , 2021, Journal of biomolecular structure & dynamics.
[5] V. Ghule,et al. 1,2,3-Triazoles of 8-Hydroxyquinoline and HBT: Synthesis and Studies (DNA Binding, Antimicrobial, Molecular Docking, ADME, and DFT) , 2021, ACS omega.
[6] F. H. Leite,et al. Thermal shift assays of marine-derived fungal metabolites from Aspergillus fischeri MMERU 23 against Leishmania major pteridine reductase 1 and molecular dynamics studies , 2021, Journal of biomolecular structure & dynamics.
[7] B. Khade,et al. Synthesis of diverse (E)‐2‐((1 H ‐imidazol‐1‐yl)methyl)‐2‐((benzyloxy)methyl)‐2,3‐dihydro‐1 H ‐inden‐1‐one O‐benzyl oxime derivatives as potent antileishmanial agents , 2020, Journal of Heterocyclic Chemistry.
[8] A. Wadood,et al. Synthesis, in vitro urease inhibitory activity and molecular docking of 3,5‐disubstituted thiadiazine‐2‐thiones , 2019, Journal of Heterocyclic Chemistry.
[9] Terry K. Smith,et al. Biological evaluation and structure activity relationship of 9-methyl-1-phenyl-9H-pyrido[3,4-b]indole derivatives as anti-leishmanial agents , 2019, Bioorganic chemistry.
[10] Muhammad Ali Minhas,et al. New series of 3,5-disubstituted tetrahydro-2H-1,3,5-thiadiazine thione (THTT) derivatives: Synthesis and potent antileishmanial activity. , 2018, Bioorganic & medicinal chemistry letters.
[11] M. Abounassif,et al. Study of Interactions of an Anticancer Drug Neratinib With Bovine Serum Albumin: Spectroscopic and Molecular Docking Approach , 2018, Front. Chem..
[12] Olivier Michielin,et al. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.
[13] P. Michels,et al. Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds. , 2015, Bioorganic & medicinal chemistry letters.
[14] S. Gibbons,et al. Fruitful decade for antileishmanial compounds from 2002 to late 2011. , 2014, Chemical reviews.
[15] J. Cano,et al. Leishmaniasis Worldwide and Global Estimates of Its Incidence , 2012, PloS one.
[16] A. Chattopadhyay,et al. A novel mechanism for an old drug: amphotericin B in the treatment of visceral leishmaniasis. , 2011, Biochemical and biophysical research communications.
[17] J. Alvar,et al. Leishmaniasis impact and treatment access. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[18] Anton J. Hopfinger,et al. 4D-QSAR: Perspectives in Drug Design , 2010, Molecules.
[19] B. Zagrovic,et al. Determination of ensemble-average pairwise root mean-square deviation from experimental B-factors. , 2010, Biophysical journal.
[20] M. Waring. Defining optimum lipophilicity and molecular weight ranges for drug candidates-Molecular weight dependent lower logD limits based on permeability. , 2009, Bioorganic & medicinal chemistry letters.
[21] V. Yardley,et al. Synthesis and Antiprotozoal Evaluation of New N4‐(Benzyl)spermidyl‐linked bis(1,3,5‐thiadiazinane‐2‐thiones) , 2008, Archiv der Pharmazie.
[22] R. Peeling,et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? , 2007, Nature Reviews Microbiology.
[23] S. Croft,et al. Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[24] Adam R Renslo,et al. Drug discovery and development for neglected parasitic diseases , 2006, Nature chemical biology.
[25] A. Gómez-Barrio,et al. Synthesis and antiprotozoan evaluation of new alkyl-linked bis(2-thioxo-[1,3,5]thiadiazinan-3-yl) carboxylic acids. , 2005, Bioorganic & medicinal chemistry.
[26] R. Coler,et al. Second-generation vaccines against leishmaniasis. , 2005, Trends in parasitology.
[27] Gert Vriend,et al. Making optimal use of empirical energy functions: Force‐field parameterization in crystal space , 2004, Proteins.
[28] P. Desjeux. Leishmaniasis: current situation and new perspectives. , 2004, Comparative immunology, microbiology and infectious diseases.
[29] V. Yardley,et al. Chemotherapy of leishmaniasis. , 2002, Current pharmaceutical design.
[30] A. El-Shorbagi. Disubstituted tetrahydro-2H-1,3,5-thiadiazine-2-thiones as lipophilic carriers for glutamine and glutamic acid , 2000 .
[31] P. Olliaro,et al. A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment. , 1995, The American journal of tropical medicine and hygiene.
[32] R. Singh,et al. Fighting against Leishmaniasis: search of alkaloids as future true potential anti-Leishmanial agents. , 2009, Mini reviews in medicinal chemistry.
[33] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[34] T. Aboul-Fadl,et al. New prodrug approach for amino acids and amino-acid-like drugs , 1996 .
[35] A. El-Shorbagi. Model for delivery of amines through incorporation into a tetrahydro-2H-1,3,5-thiadiazine-2-thione structure , 1994 .
[36] G. Dalekos,et al. Leishmaniasis revisited: Current aspects on epidemiology, diagnosis and treatment , 2015, Journal of translational internal medicine.